Reference Identification

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria.

Ann Rheum Dis, Valentini G, Bencivelli W, Bombardieri S, D'Angelo S, Della Rossa A, Silman AJ, Black CM, Czirjak L, Nielsen H, Vlachoyiannopoulos PG. dis 2003; 62:901-3
Country: Italy
Language: English
https://ard.bmj.com/content/62/9/901.long

Other references of interest

https://pubmed.ncbi.nlm.nih.gov/31422354/

Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual. 

Assessment of the predictive value for short-term disease severity accrual of the EUSTAR-AI, as compared with those of the EScSG-AI and of known adverse prognostic factors.

https://pubmed.ncbi.nlm.nih.gov/20236952/

Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis, Rheumatology. 

Evaluation of the construct validity of the European Scleroderma Study Group (EScSG) activity index and modifications proposal.

https://pubmed.ncbi.nlm.nih.gov/33091259/

An Update of Outcome Measures in Systemic Sclerosis. Arthritis Care & Research. 

Review  to update various outcome measurements in SSc that have been used in clinical trials and/or have testing characteristics published, such as reliability and sensitivity to change.

Instrument/Tool Translations References

---